US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Latest News about Health & Science

Recent news which mentions Health & Science

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
FDA shuffles top drug, biologics leaders in latest shakeup
Tags White House Health & Science Politics
From CNBC.com News
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
Tags Pfizer Inc Eli Lilly and Co Bristol/Myers Squibb Co
From CNBC.com News
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Tags Eli Lilly and Co Health & Science Health care industry
From CNBC.com News
Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness
Tags Pharmaceuticals Business Biotech and Pharmaceuticals
From CNBC.com News
Trump says Makary is out as FDA commissioner, following industry and White House backlash
Tags Business Pharmaceuticals Uniqure NV
From CNBC.com News
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Tags Biotech and Pharmaceuticals Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Jim Cramer says today’s market is punishing stocks harder than 1999
Tags Business News Stryker Corp Stock markets
From CNBC.com News
Hantavirus cases spark surge in pharma and biotech stocks — here’s why
Tags Moderna Inc Vaccinations Immunizations
From CNBC.com News
MV Hondius hantavirus outbreak: A luxury expedition cruise boom and new world of remote travel risks
Tags Luxury Brown & Brown Inc Marine
From CNBC.com News
Fitness wearable Whoop to offer on-demand clinician access to U.S. users
Tags Health & Science Breaking News: Technology Technology
From CNBC.com News
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
Tags Healthy Returns Novo Nordisk A/S Health care industry
From CNBC.com News
Planet Fitness stock plunges 30% after company slashes guidance, cancels planned price hikes
Tickers LIFE
Tags Health & Science Life Retail
From CNBC.com News
Family office deal-making rebounds in April with healthcare bets
Tags Inside Wealth Business News Business
From CNBC.com News
Rare disease families find roadmap to drug development at bootcamps
Tags Biotechnology Health & Science Ultragenyx Pharmaceutical Inc
From CNBC.com News
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Tags Mergers Health & Science Novo Nordisk A/S
From CNBC.com News
Wearable patches: How Barrière is trying to disrupt the supplement industry
Tickers LIFE
Tags Business News Target Corp Retail
From CNBC.com News
CVS blows past estimates, hikes outlook as insurance business outperforms
Tags US: News Health & Science Dividends
From CNBC.com News
FDA withdrew studies finding Covid, shingles vaccines were safe
Tags GSK plc Health care industry Breaking News: Business
From CNBC.com News
FDA commissioner defends agency's drug approval decisions after wave of backlash
Tags Health & Science Politics Replimune Group Inc
From CNBC.com News
Major health insurers show signs of recovery – but a key test looms
Tags Health & Science Humana Inc US: News
From CNBC.com News
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
Tags Pfizer Inc Business News Biotechnology
From CNBC.com News
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Tags LifeMD Inc Health & Science Eli Lilly and Co
From CNBC.com News
Weight loss and hair loss: The growing hair treatment market from GLP-1s
Tags Eli Lilly and Co Biotech and Pharmaceuticals Accenture PLC
From CNBC.com News
CDC director Susan Monarez ousted weeks after being sworn in
Tags Business News Breaking News: Politics Congress
From CNBC.com News
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags UnitedHealth Group Inc Novo Nordisk A/S Healthy Returns
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Novo Nordisk A/S Health care industry Breaking News: Business
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Hotels and Leisure Food and drink Danone SA
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags US: News Structure Therapeutics Inc Health & Science
From CNBC.com News
Microplastics are everywhere. Here's why that matters to big oil
Tags Chemicals Health care industry Consumer safety
From CNBC.com News
Epic touts new AI tools for patients and doctors at company's annual meeting
Tags Oracle Corp Enterprise Media
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >